New research suggests that, for some rosacea sufferers, the condition may be linked to their gut.1
In a small pilot study published as a letter in the Journal of the American Academy of Dermatology, about half of 63 rosacea patients also had small intestinal bacteria overgrowth, or SIBO. After localized treatment for SIBO, 46 percent of these patients reported marked improvement of their rosacea symptoms.
The researchers noted that further study would contribute to an understanding of the potential significance of these findings. The study was reported by Dr. Martin Steinhoff, professor of dermatology at the University of California-San Francisco, and Dr. Leonard Weinstock, associate professor of clinical medicine at Washington University.
1. Weinstock LB, Steinhoff M. Rosacea and small intestinal bacterial overgrowth: Prevalence and response to rifaximin. Journal of the American Academy of Dermatology 2013;68:875-876.
The National Rosacea Society is a 501(c)(3) nonprofit organization whose mission is to improve the lives of people with rosacea by raising awareness, providing public health information and supporting medical research on this widespread but little-known disorder. The information the Society provides should not be considered medical advice, nor is it intended to replace
consultation with a qualified physician. The Society does not evaluate, endorse or recommend any particular medications, products, equipment or treatments. Rosacea may vary substantially from one patient to another, and treatment must be tailored by a physician for each individual case. For more information, visit About Us.